817
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

ApoB, non-HDL-C, and LDL-C Are More Prominent in Retinal Artery Occlusion Compared to Retinal Vein Occlusion

, PhDORCID Icon, , MD, , MD, , MD, , MD & , PhD
Pages 534-540 | Received 05 Aug 2022, Accepted 22 Jan 2023, Published online: 09 Feb 2023

References

  • Scott IU, Campochiaro PA, Newman NJ, Biousse V. Retinal vascular occlusions[J]. Lancet. 2020;396:1927–1940. doi:10.1016/S0140-6736(20)31559-2.
  • Mac Grory B, Schrag M, Biousse V, et al. Management of central retinal artery occlusion: a scientific statement from the American Heart Association[J]. Stroke. 2021;52:e282–e294. doi:10.1161/STR.0000000000000366.
  • Rogers SL, Mcintosh RL, Lim L, et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review[J]. Ophthalmology. 2010;117:1094–1101.e5. doi:10.1016/j.ophtha.2010.01.058.
  • Mirshahi A, Feltgen N, Hansen LL, Hattenbach LO. Retinal vascular occlusions: an interdisciplinary challenge[J]. Dtsch Arztebl Int. 2008;105:474–479. doi:10.3238/arztebl.2008.0474.
  • Hayreh SS. Prevalent misconceptions about acute retinal vascular occlusive disorders[J]. Prog Retin Eye Res. 2005;24:493–519. doi:10.1016/j.preteyeres.2004.12.001.
  • Geovanini GR, Libby P. Atherosclerosis and inflammation: overview and updates[J]. Clin Sci (Lond). 2018;132:1243–1252. doi:10.1042/CS20180306.
  • Wolf D, Ley K. Immunity and inflammation in atherosclerosis[J]. Circ Res. 2019;124:315–327. doi:10.1161/CIRCRESAHA.118.313591.
  • Guven S, Kilic D. Neutrophil to Lymphocyte Ratio (NLR) is a better tool rather than Monocyte to High-Density Lipoprotein Ratio (MHR) and Platelet to Lymphocyte Ratio (PLR) in central retinal artery occlusions[J]. Ocul Immunol Inflamm. 2021;29:997–1001. doi:10.1080/09273948.2020.1712433.
  • Stojakovic T, Scharnagl H, März W, et al. Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion[J]. Clin Chim Acta. 2007;382:77–81. doi:10.1016/j.cca.2007.03.024.
  • Hwang S, Kang SW, Choi KJ, et al. High-density lipoprotein cholesterol and the risk of future retinal artery occlusion development: a nationwide cohort study[J]. Am J Ophthalmol. 2022;235:188–196. doi:10.1016/j.ajo.2021.09.027.
  • Nguyen TT, Islam FM, Farouque HM, et al. Retinal vascular caliber and brachial flow-mediated dilation: the multi-ethnic study of atherosclerosis[J]. Stroke. 2010;41:1343–1348. doi:10.1161/STROKEAHA.110.581017.
  • Curcio CA, Johnson M, Rudolf M, Huang JD. The oil spill in ageing Bruch membrane[J]. Br J Ophthalmol. 2011;95:1638–1645. doi:10.1136/bjophthalmol-2011-300344.
  • Woo SC, Lip GY, Lip PL. Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review[J]. Eye (Lond). 2016;30:1031–1038. doi:10.1038/eye.2016.111.
  • Ponto KA, Scharrer I, Binder H, et al. Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the Gutenberg retinal vein occlusion study[J]. J Hypertens. 2019;37:1372–1383. doi:10.1097/HJH.0000000000002057.
  • Callizo J, Feltgen N, Pantenburg S, et al. Cardiovascular risk factors in central retinal artery occlusion: results of a prospective and standardized medical examination[J]. Ophthalmology. 2015;122:1881–1888. doi:10.1016/j.ophtha.2015.05.044.
  • Cao J, Nomura SO, Steffen BT, et al. Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the multi-ethnic study of atherosclerosis (mesa)[J]. J Clin Lipidol. 2020;14:109–121.e5. doi:10.1016/j.jacl.2019.11.005.
  • St-Pierre AC, Cantin B, Dagenais GR, et al. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men[J]. Am J Cardiol. 2006;97:997–1001. doi:10.1016/j.amjcard.2005.10.060.
  • Ramjee V, Sperling LS, Jacobson TA. Non-high-density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math[J]. J Am Coll Cardiol. 2011;58:457–463. doi:10.1016/j.jacc.2011.05.009.
  • Stock J. Triglycerides and cardiovascular risk: apolipoprotein B holds the key[J]. Atherosclerosis. 2019;284:221–222. doi:10.1016/j.atherosclerosis.2019.03.004.
  • Björnson E, Packard CJ, Adiels M, et al. Apolipoprotein B48 metabolism in chylomicrons and very low-density lipoproteins and its role in triglyceride transport in normo- and hypertriglyceridemic human subjects[J]. J Intern Med. 2020;288:422–438. doi:10.1111/joim.13017.
  • Cole TG, Contois JH, Csako G, et al. Association of apolipoprotein B and nuclear magnetic resonance spectroscopy-derived LDL particle number with outcomes in 25 clinical studies: assessment by the AACC lipoprotein and vascular diseases division working group on best practices[J]. Clin Chem. 2013;59:752–770. doi:10.1373/clinchem.2012.196733.
  • Elbeyli A, Kurtul BE, Ozcan DO, et al. Assessment of red cell distribution width, platelet/lymphocyte ratio, systemic immune-inflammation index, and neutrophil/lymphocyte ratio values in patients with central retinal artery occlusion[J]. Ocul Immunol Inflamm. 2022;30:1940–1944. doi:10.1080/09273948.2021.1976219.
  • Ben-Aicha S, Badimon L, Vilahur G. Advances in HDL: much more than lipid transporters[J]. Int J Mol Sci. 2020;21:732. doi:10.3390/ijms21030732.
  • Xu X, Song Z, Mao B, Xu G. Apolipoprotein A1-related proteins and reverse cholesterol transport in antiatherosclerosis therapy: recent progress and future perspectives[J]. Cardiovasc Ther. 2022;2022:4610834. doi:10.1155/2022/4610834.
  • Ouimet M, Barrett TJ, Fisher EA. HDL and reverse cholesterol transport[J]. Circ Res. 2019;124:1505–1518. doi:10.1161/CIRCRESAHA.119.312617.
  • Oslakovic C, Krisinger MJ, Andersson A, et al. Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins[J]. J Biol Chem. 2009;284:5896–5904. doi:10.1074/jbc.M807286200.
  • Buch H, Vinding T, La Cour M, et al. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study[J]. Acta Ophthalmol Scand. 2005;83:409–418. doi:10.1111/j.1600-0420.2005.00492.x.
  • Sasongko MB, Wong TY, Nguyen TT, et al. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids[J]. Diabetes Care. 2011;34:474–479. doi:10.2337/dc10-0793.
  • Gratchev A, Sobenin I, Orekhov A, Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases[J]. Immunobiology. 2012;217:476–482. doi:10.1016/j.imbio.2012.01.008.
  • Duru Z, Altunel O, Alabay B, et al. Elevated monocyte-to-high-density lipoprotein ratio as an indicator of systemic inflammation in patients with branch retinal vein occlusion[J]. Beyoglu Eye J. 2021;6:212–216. doi:10.14744/bej.2021.94547.
  • Marcinkowska A, Wolska N, Luzak B, et al. Platelet-derived procoagulant microvesicles are elevated in patients with Retinal Vein Occlusion (RVO)[J]. J Clin Med. 2022;11:5099. doi:10.3390/jcm11175099.
  • Marcinkowska A, Cisiecki S, Rozalski M. Platelet and thrombophilia-related risk factors of retinal vein occlusion[J]. J Clin Med. 2021;10:3080. doi:10.3390/jcm10143080.
  • Liu Z, Perry LA, Edwards TL. Association between platelet indices and retinal vein occlusion: a systematic review and meta-analysis[J]. Retina. 2021;41:238–248. doi:10.1097/IAE.0000000000003022.